Mathew Leveridge
Papers
1
Total Citations
23
H-Index
1
About
Mathew Leveridge is a neuroscientist whose work has advanced the use of human neural stem cells for drug discovery and disease modeling. His most-cited paper, "Non-immortalized human neural stem (NS) cells as a scalable platform for cellular assays" (2011, 23 citations), established a critical methodology for generating stable, non-immortalized neural stem cell lines. This contribution provided a more physiologically relevant and scalable alternative to traditional immortalized or primary cell models, enabling high-throughput screening for neurological disorders. Leveridge’s research focuses on developing reproducible cellular assays that bridge the gap between basic neurobiology and translational applications, particularly in areas such as neurodegeneration and neurotoxicity. His work has been instrumental in demonstrating how human-derived NS cells can be cultured long-term without genetic transformation, preserving their native characteristics for more accurate drug testing. By providing a robust platform for phenotypic and target-based screens, Leveridge has helped accelerate the identification of therapeutic candidates for conditions like Alzheimer’s and Parkinson’s disease. His approach underscores the importance of cell source and culture conditions in preclinical research, offering a valuable tool for both academic and pharmaceutical laboratories seeking to improve the predictive power of cellular models.
Research Focus
Key Achievements
Top Papers
- 1